{"title": "Pfizer Statement Regarding Prevnar 13\u00ae Receiving ACIP Recommendation for Prevention of Pneumococcal Disease in Adults With Immunocompromising Conditions", "author": "Damian Garde", "url": "https://www.fiercepharma.com/pharma/pfizer-statement-regarding-prevnar-13%C2%AE-receiving-acip-recommendation-for-prevention-of", "hostname": "fiercepharma.com", "description": "NEW YORK--Pfizer Inc (NYSE: PFE) issued the following statement in response to today's Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) vote to... | NEW YORK--Pfizer Inc (NYSE: PFE) issued the following statement in response to today's Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) vote to...", "sitename": "FiercePharma", "date": "2012-06-21", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Subscribe Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}